Morepen Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

79.89

-3.36 (-4.04%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

79.89

-3.36 (-4.04%)
16:02 Dec 20

Quality

59/100
High Financial Strength

Valuation

43/100
Mid Valuation

Technical

58/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1188.06	1546.83	1417.53	1690.43	1760.57
Operating Expenses +	1069.54	1410.16	1338	1531.81	1565.93
Raw Material	822.13	1059.36	939.26	1060.31	1118.03
Increase Decrease in Cost	-41.58	-10.04	16.48	2.11	-36.57
Other Manufacturing Expense	0	0	0	0	28.55
Employee Cost	135.59	164.25	154.68	181.47	192.37
Miscellaneous Expenses	561.8	721.05	543.28	641.92	263.55
Operating Profit	118.52	136.67	79.53	158.62	194.64
Other Income	12.07	10.31	6.13	13.97	16.73
Depreciation	30.28	27.64	27.93	33.47	25.66
Interest	1.79	-7.37	1.98	3.71	5.3
Profit before tax and exceptio..	98.51	126.7	55.76	135.42	180.41
Exceptional Items	0	0	0	0	0
PBT	98.51	126.7	55.76	135.42	180.41
Provision for Taxation	1.42	25.02	17.08	38.8	48.66
Net Profit	97.09	101.68	38.68	96.62	131.75
NET Profit after MI	97.09	101.68	38.68	96.16	131.29
EPS	2.16	2.26	0.77	1.88	2.53
Operating Profit Margin (%)	9.98	8.84	5.61	9.38	11.06
Net Profit Margin (%)	8.17	6.57	2.73	5.69	7.46

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	35.60	38.20	38.20	38.20	38.20
FII	2.10	1.70	1.80	2.10	1.30
MF	0.00	0.00	0.00	0.00	0.00
Public	60.60	58.00	57.80	57.40	58.20
Others	0.00	0.00	0.00	0.10	0.00
Others	1.70	2.10	2.20	2.20	2.30